Cargando…

Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?

PURPOSE: This study aims to incorporate informative histogram indicator analyses and advanced multimodal MRI parameters to differentiate low-grade gliomas (LGGs) from high-grade gliomas (HGGs) and to explore the features associated with patients’ survival. PATIENTS AND METHODS: A total of 120 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Lin-Feng, Sun, Ying-Zhi, Zhao, Sha-Sha, Hu, Yu-Chuan, Han, Yu, Li, Gang, Zhang, Xin, Tian, Qiang, Liu, Zhi-Cheng, Yang, Yang, Nan, Hai-Yan, Yu, Ying, Sun, Qian, Zhang, Jin, Chen, Ping, Hu, Bo, Li, Fei, Han, Teng-Hui, Wang, Wen, Cui, Guang-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885544/
https://www.ncbi.nlm.nih.gov/pubmed/31819632
http://dx.doi.org/10.2147/CMAR.S197839
_version_ 1783474752364478464
author Yan, Lin-Feng
Sun, Ying-Zhi
Zhao, Sha-Sha
Hu, Yu-Chuan
Han, Yu
Li, Gang
Zhang, Xin
Tian, Qiang
Liu, Zhi-Cheng
Yang, Yang
Nan, Hai-Yan
Yu, Ying
Sun, Qian
Zhang, Jin
Chen, Ping
Hu, Bo
Li, Fei
Han, Teng-Hui
Wang, Wen
Cui, Guang-Bin
author_facet Yan, Lin-Feng
Sun, Ying-Zhi
Zhao, Sha-Sha
Hu, Yu-Chuan
Han, Yu
Li, Gang
Zhang, Xin
Tian, Qiang
Liu, Zhi-Cheng
Yang, Yang
Nan, Hai-Yan
Yu, Ying
Sun, Qian
Zhang, Jin
Chen, Ping
Hu, Bo
Li, Fei
Han, Teng-Hui
Wang, Wen
Cui, Guang-Bin
author_sort Yan, Lin-Feng
collection PubMed
description PURPOSE: This study aims to incorporate informative histogram indicator analyses and advanced multimodal MRI parameters to differentiate low-grade gliomas (LGGs) from high-grade gliomas (HGGs) and to explore the features associated with patients’ survival. PATIENTS AND METHODS: A total of 120 patients with pathologically confirmed LGGs or HGGs receiving conventional and advanced MRI such as three-dimensional arterial spin labeling (3D-ASL), intravoxel incoherent motion-diffusion weighted imaging (IVIM-DWI), and dynamic contrast-enhanced MRI (DCE-MRI) were included. The mean and histogram indicators from advanced MRI were calculated from the entire tumor. The efficacies of a single indicator or multiple parameters were tested in distinguishing HGGs from LGGs and predicting patients’ survival. Receiver operating characteristic (ROC) curve and multivariable stepwise logistic regression were used to evaluate the diagnostic efficacies. Leave-one-out cross-validation was further used to validate the accuracy of the parameter sets in glioma grading. Log-rank test using the Kaplan–Meier curve was utilized to predict patients’ survival. RESULTS: Overall, parameters from DCE-MRI performed better than those from 3D-ASL or IVIM-DWI in both glioma grading and survival prediction. The histogram metrics of V(e) were demonstrated to have higher accuracies (the accuracies for Extended Tofts_V(e)(mean) and Extended Tofts_V(e)(median) were 68.33% and 71.67%, respectively, while those for the Incremental_V(e)(mean) and Incremental_V(e)(75th) were 68.33% and 72.50%, respectively) in grading LGGs from HGGs. The combination of Tofts_V(e) histogram metrics was the one with the highest accuracy (81.67%) and area under ROC curve (AUC = 0.840). On the other hand, Patlak_K(trans)(95th) (AUC = 0.9265) and Extended Tofts_V(e)(95th) (AUC = 0.9154) performed better than their corresponding means (Patlak_K(trans)(mean): AUC = 0.9118 and Extended Tofts_V(e)(mean): AUC = 0.9044) in predicting patients’ overall survival (OS) at 18-month follow-up. CONCLUSION: DCE-MRI-derived histogram features from the entire tumor were promising metrics for glioma grading and OS prediction. Combining single modal histogram features improved glioma grading. TRIAL REGISTRATION: NCT 02622620.
format Online
Article
Text
id pubmed-6885544
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-68855442019-12-09 Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best? Yan, Lin-Feng Sun, Ying-Zhi Zhao, Sha-Sha Hu, Yu-Chuan Han, Yu Li, Gang Zhang, Xin Tian, Qiang Liu, Zhi-Cheng Yang, Yang Nan, Hai-Yan Yu, Ying Sun, Qian Zhang, Jin Chen, Ping Hu, Bo Li, Fei Han, Teng-Hui Wang, Wen Cui, Guang-Bin Cancer Manag Res Original Research PURPOSE: This study aims to incorporate informative histogram indicator analyses and advanced multimodal MRI parameters to differentiate low-grade gliomas (LGGs) from high-grade gliomas (HGGs) and to explore the features associated with patients’ survival. PATIENTS AND METHODS: A total of 120 patients with pathologically confirmed LGGs or HGGs receiving conventional and advanced MRI such as three-dimensional arterial spin labeling (3D-ASL), intravoxel incoherent motion-diffusion weighted imaging (IVIM-DWI), and dynamic contrast-enhanced MRI (DCE-MRI) were included. The mean and histogram indicators from advanced MRI were calculated from the entire tumor. The efficacies of a single indicator or multiple parameters were tested in distinguishing HGGs from LGGs and predicting patients’ survival. Receiver operating characteristic (ROC) curve and multivariable stepwise logistic regression were used to evaluate the diagnostic efficacies. Leave-one-out cross-validation was further used to validate the accuracy of the parameter sets in glioma grading. Log-rank test using the Kaplan–Meier curve was utilized to predict patients’ survival. RESULTS: Overall, parameters from DCE-MRI performed better than those from 3D-ASL or IVIM-DWI in both glioma grading and survival prediction. The histogram metrics of V(e) were demonstrated to have higher accuracies (the accuracies for Extended Tofts_V(e)(mean) and Extended Tofts_V(e)(median) were 68.33% and 71.67%, respectively, while those for the Incremental_V(e)(mean) and Incremental_V(e)(75th) were 68.33% and 72.50%, respectively) in grading LGGs from HGGs. The combination of Tofts_V(e) histogram metrics was the one with the highest accuracy (81.67%) and area under ROC curve (AUC = 0.840). On the other hand, Patlak_K(trans)(95th) (AUC = 0.9265) and Extended Tofts_V(e)(95th) (AUC = 0.9154) performed better than their corresponding means (Patlak_K(trans)(mean): AUC = 0.9118 and Extended Tofts_V(e)(mean): AUC = 0.9044) in predicting patients’ overall survival (OS) at 18-month follow-up. CONCLUSION: DCE-MRI-derived histogram features from the entire tumor were promising metrics for glioma grading and OS prediction. Combining single modal histogram features improved glioma grading. TRIAL REGISTRATION: NCT 02622620. Dove 2019-11-27 /pmc/articles/PMC6885544/ /pubmed/31819632 http://dx.doi.org/10.2147/CMAR.S197839 Text en © 2019 Yan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yan, Lin-Feng
Sun, Ying-Zhi
Zhao, Sha-Sha
Hu, Yu-Chuan
Han, Yu
Li, Gang
Zhang, Xin
Tian, Qiang
Liu, Zhi-Cheng
Yang, Yang
Nan, Hai-Yan
Yu, Ying
Sun, Qian
Zhang, Jin
Chen, Ping
Hu, Bo
Li, Fei
Han, Teng-Hui
Wang, Wen
Cui, Guang-Bin
Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
title Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
title_full Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
title_fullStr Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
title_full_unstemmed Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
title_short Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
title_sort perfusion, diffusion, or brain tumor barrier integrity: which represents the glioma features best?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885544/
https://www.ncbi.nlm.nih.gov/pubmed/31819632
http://dx.doi.org/10.2147/CMAR.S197839
work_keys_str_mv AT yanlinfeng perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT sunyingzhi perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT zhaoshasha perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT huyuchuan perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT hanyu perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT ligang perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT zhangxin perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT tianqiang perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT liuzhicheng perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT yangyang perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT nanhaiyan perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT yuying perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT sunqian perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT zhangjin perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT chenping perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT hubo perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT lifei perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT hantenghui perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT wangwen perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest
AT cuiguangbin perfusiondiffusionorbraintumorbarrierintegritywhichrepresentsthegliomafeaturesbest